13-113110704-G-A
Variant summary
Our verdict is Likely benign. Variant got -2 ACMG points: 2P and 4B. PM2BP4_Strong
The NM_019616.4(F7):c.79G>A(p.Glu27Lys) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.000198 in 1,548,582 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. 13/21 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (★).
Frequency
Consequence
NM_019616.4 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Likely_benign. Variant got -2 ACMG points.
Transcripts
RefSeq
Ensembl
Frequencies
GnomAD3 genomes AF: 0.00116 AC: 176AN: 152210Hom.: 0 Cov.: 33
GnomAD3 exomes AF: 0.000229 AC: 35AN: 152744Hom.: 0 AF XY: 0.000136 AC XY: 11AN XY: 80980
GnomAD4 exome AF: 0.0000931 AC: 130AN: 1396260Hom.: 0 Cov.: 31 AF XY: 0.0000697 AC XY: 48AN XY: 688682
GnomAD4 genome AF: 0.00116 AC: 176AN: 152322Hom.: 0 Cov.: 33 AF XY: 0.00106 AC XY: 79AN XY: 74478
ClinVar
Submissions by phenotype
Inborn genetic diseases Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Ambry Genetics | Jan 07, 2022 | The c.145G>A (p.E49K) alteration is located in exon 3 (coding exon 3) of the F7 gene. This alteration results from a G to A substitution at nucleotide position 145, causing the glutamic acid (E) at amino acid position 49 to be replaced by a lysine (K). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at